⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for digestive system neoplasm

Every month we try and update this database with for digestive system neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionNCT03549494
Stomach Neoplas...
Gastrointestina...
Digestive Syste...
Esophageal Neop...
Head and Neck N...
Gastrointestina...
Digestive Syste...
Esophageal Dise...
Stomach Disease...
Esophagogastric...
Ocoxin-Viusid®
18 Years - Catalysis SL
A Clinicobiological Database in Metastatic Digestive CancersNCT03978078
Digestive Syste...
Biological coll...
18 Years - Institut du Cancer de Montpellier - Val d'Aurelle
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)NCT05160168
Gastrointestina...
Neoplasms, Conn...
Neoplasms, Conn...
Neoplasms by Hi...
Neoplasms
Gastrointestina...
Digestive Syste...
Digestive Syste...
Gastrointestina...
THE-630
18 Years - Theseus Pharmaceuticals
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerNCT03535727
Adenocarcinoma
Pancreatic Neop...
Neoplasm, Gland...
Neoplasms
Neoplasms Pancr...
Digestive Syste...
Endocrine Gland...
Digestive Syste...
Pancreatic Dise...
Endocrine Syste...
Nab-paclitaxel
Gemcitabine
Capecitabine
Cisplatin
Irinotecan
Nab-paclitaxel
Gemcitabine
Capecitabine
Cisplatin
Irinotecan
18 Years - 76 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Prospective Observational StudyNCT04500990
Immunotherapy
Digestive Syste...
MRI test
MRI test
MRI test
18 Years - Peking University
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyNCT04456140
Breast Carcinom...
Digestive Syste...
Malignant Brain...
Malignant Centr...
Malignant Femal...
Malignant Genit...
Malignant Head ...
Malignant Muscu...
Malignant Solid...
Metastatic Mali...
Skin Carcinoma
Biospecimen Col...
Genetic Counsel...
Genetic Testing
Survey Administ...
18 Years - Mayo Clinic
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyNCT04456140
Breast Carcinom...
Digestive Syste...
Malignant Brain...
Malignant Centr...
Malignant Femal...
Malignant Genit...
Malignant Head ...
Malignant Muscu...
Malignant Solid...
Metastatic Mali...
Skin Carcinoma
Biospecimen Col...
Genetic Counsel...
Genetic Testing
Survey Administ...
18 Years - Mayo Clinic
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyNCT04456140
Breast Carcinom...
Digestive Syste...
Malignant Brain...
Malignant Centr...
Malignant Femal...
Malignant Genit...
Malignant Head ...
Malignant Muscu...
Malignant Solid...
Metastatic Mali...
Skin Carcinoma
Biospecimen Col...
Genetic Counsel...
Genetic Testing
Survey Administ...
18 Years - Mayo Clinic
Gastrointestinal Anastomosis Using MonoPlus® SutureNCT04811833
Gastrointestina...
Gastrointestina...
Digestive Syste...
Stomach Tumor
Small Intestine...
Colon Tumor
Rectum Tumor
18 Years - Aesculap AG
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsNCT03037385
RET-altered Non...
Medullary Thyro...
RET-altered Pap...
RET-altered Col...
RET-altered Sol...
Lung Neoplasm
Carcinoma, Non-...
Thyroid Disease...
Thyroid Neoplas...
Thyroid Cancer,...
Carcinoma, Neur...
Respiratory Tra...
Thoracic Neopla...
Neoplasms by Si...
Neoplasms
Lung Diseases
Respiratory Tra...
Carcinoma, Bron...
Bronchial Neopl...
Endocrine Syste...
Endocrine Gland...
Head and Neck N...
Adenocarcinoma,...
Adenocarcinoma
Carcinoma
Neoplasms, Glan...
Neoplasms by Hi...
Neuroendocrine ...
Neuroectodermal...
Neoplasms, Germ...
Neoplasms, Nerv...
Colonic Neoplas...
Colorectal Neop...
Intestinal Neop...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Gastrointestina...
Colonic Disease...
Intestinal Dise...
pralsetinib (BL...
18 Years - Hoffmann-La Roche
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsNCT02602067
Breast Neoplasm
Head and Neck N...
Skin Neoplasm
Respiratory Tra...
Urogenital Neop...
Digestive Syste...
Pancreatic Neop...
Connective and ...
Lymphoma, Non-H...
131I-Tenatumoma...
18 Years - 75 Yearssigma-tau i.f.r. S.p.A.
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention TrialNCT04084249
Colorectal Canc...
Colo-rectal Can...
ctDNA
Gastro-Intestin...
Colorectal Neop...
Gastrointestina...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Colonic Disease...
Colonic Neoplas...
Colonic Cancer
Rectal Diseases
Rectal Neoplasm...
Rectal Cancer
ctDNA-analysis
Intensified Fol...
18 Years - University of Aarhus
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaNCT03559543
Colorectal Neop...
Intestinal Neop...
Gastrointestina...
Digestive Syste...
Rectal Diseases
Colonic Disease...
Intestinal Dise...
Gastrointestina...
Digestive Syste...
Ocoxin-Viusid
18 Years - Catalysis SL
Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.NCT03724071
Colorectal Neop...
Digestive Syste...
TG6002
Flucytosine (5-...
18 Years - Transgene
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionNCT03549494
Stomach Neoplas...
Gastrointestina...
Digestive Syste...
Esophageal Neop...
Head and Neck N...
Gastrointestina...
Digestive Syste...
Esophageal Dise...
Stomach Disease...
Esophagogastric...
Ocoxin-Viusid®
18 Years - Catalysis SL
Gastrointestinal Anastomosis Using MonoPlus® SutureNCT04811833
Gastrointestina...
Gastrointestina...
Digestive Syste...
Stomach Tumor
Small Intestine...
Colon Tumor
Rectum Tumor
18 Years - Aesculap AG
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaNCT03559543
Colorectal Neop...
Intestinal Neop...
Gastrointestina...
Digestive Syste...
Rectal Diseases
Colonic Disease...
Intestinal Dise...
Gastrointestina...
Digestive Syste...
Ocoxin-Viusid
18 Years - Catalysis SL
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsNCT02602067
Breast Neoplasm
Head and Neck N...
Skin Neoplasm
Respiratory Tra...
Urogenital Neop...
Digestive Syste...
Pancreatic Neop...
Connective and ...
Lymphoma, Non-H...
131I-Tenatumoma...
18 Years - 75 Yearssigma-tau i.f.r. S.p.A.
Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal TumorsNCT06223230
Digestive Syste...
Digestive Syste...
Nutritional psy...
18 Years - 75 YearsRenmin Hospital of Wuhan University
Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal TumorsNCT06223230
Digestive Syste...
Digestive Syste...
Nutritional psy...
18 Years - 75 YearsRenmin Hospital of Wuhan University
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention TrialNCT04084249
Colorectal Canc...
Colo-rectal Can...
ctDNA
Gastro-Intestin...
Colorectal Neop...
Gastrointestina...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Colonic Disease...
Colonic Neoplas...
Colonic Cancer
Rectal Diseases
Rectal Neoplasm...
Rectal Cancer
ctDNA-analysis
Intensified Fol...
18 Years - University of Aarhus
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)NCT04929015
Appendix Carcin...
Colorectal Carc...
Digestive Syste...
Esophageal Carc...
Gastric Carcino...
Liver and Intra...
Peritoneal Carc...
Biospecimen Col...
Electronic Heal...
18 Years - Rutgers, The State University of New Jersey
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: